Pre- and post- transplantation lung cancer in heart transplant recipients.

Abstract

Heart transplantation after lung cancer surgery can be questionable because of the high risk of cancer recurrence. We report the results of two patients. The first underwent right lobectomy in 2008 for pT1N0 adenocarcinoma, heart-transplantation in 2010, and surgery for synchronous adenocarcinoma and squamous-cell carcinoma in 2012. The second underwent left segmentectomy for pT1aN0 adenosquamous carcinoma and transplantation in 1995 and then surgery for pT1aN1 adenocarcinoma in 2013. Posttransplantation lung cancer histologic analysis results were different in both cases, demonstrating the absence of metastatic recurrence. Thus, early stage lung cancer might not be a contraindication to heart transplantation, nor are long delays be necessary before registering on a waiting list.

• Authors: Ciprian Pricopi, Caroline Rivera, Shaida Varnous, Alex Arame, Françoise Le Pimpec Barthes, Marc Riquet
• Journal: The Annals of thoracic surgery (Ann Thorac Surg) Vol. 99 Issue 5 Pg. 1793-4 (May 2015) ISSN: 1552-6259 [Electronic] Netherlands
• PMID: 25952208 (Publication Type: Case Reports, Journal Article)
• Copyright: Copyright © 2015 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Topics

• Adenocarcinoma (complications, pathology, surgery)
• Carcinoma, Adenosquamous (complications, pathology, surgery)
• Carcinoma, Squamous Cell (complications, pathology, surgery)
• Heart Failure (complications, surgery)
• Heart Transplantation
• Humans
• Lung Neoplasms (complications, pathology, surgery)
• Male
• Middle Aged
• Neoplasms, Multiple Primary (complications, pathology, surgery)
• Pneumonectomy